Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06446479

Effects of THC on Alcohol Consumption and Neural Correlates of Reward

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
28 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
21 Years – 40 Years
Healthy volunteers
Accepted

Summary

Alcohol and cannabis are often used together such that their effects overlap, but little is known about the neural mechanisms that underlie simultaneous use. High doses of THC have not been well-studied in the laboratory, and it is unclear how high doses of THC may impact alcohol consumption patterns. The proposed study will explore the effects of oral THC (20mg dronabinol) vs. placebo on neural reward, alcohol self-administration and naturalistic co-use patterns.

Detailed description

Participants will undergo a screening assessment, baseline session and two laboratory visits. The laboratory visits will involve an MRI scan and the opportunity to consume alcohol in our BAR lab. Prior to the MRI, participants will consume, a placebo (0mg) or high (20mg) dose of oral THC (dronabinol). Visits will be separated by 7 to 14 days. Dronabinol is an FDA-approved product that will be dispensed by our on-campus pharmacy

Conditions

Interventions

TypeNameDescription
DRUGDronabinol PillDronabinol 20 mg
DRUGPlaceboplacebo

Timeline

Start date
2024-07-01
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2024-06-06
Last updated
2024-08-19

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06446479. Inclusion in this directory is not an endorsement.